My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Lexeo Therapeutics, Inc. - Common Stock (NQ:LXEO)

3.280 -0.130 (-3.81%)

Delayed Quote Updated: 1:28 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Lexeo Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >

Keep an eye on the top gainers and losers in Monday's session. ↗

January 12, 2026

Via Chartmill

Top stock movements in today's session. ↗

January 12, 2026

Via Chartmill

Gapping stocks in Monday's session ↗

January 12, 2026

Via Chartmill

Lexeo Therapeutics Stock Hits 11-Month High On Bullish Analyst Calls For Friedreich’s Ataxia Gene Therapy — Retail Traders Join In ↗

October 08, 2025

Via Stocktwits

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 07, 2025

Via Benzinga

Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process ↗

October 07, 2025

Via Stocktwits

James Hardie Industries, AMD, Trilogy Metals, BTQ Technologies And Other Big Stocks Moving Higher On Tuesday ↗

October 07, 2025

Via Benzinga

Tuesday's session: gap up and gap down stocks ↗

October 07, 2025

The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

October 07, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 24, 2025

Via Benzinga

FDA Outlines Process To Speed Up Rare Disease Therapy Approvals ↗

September 04, 2025

FDA launches Rare Disease Evidence Principles to guide therapy reviews, offering new pathways for approval while raising questions on development impact.

Via Benzinga

Lexeo Reports Q2 Loss as Costs Jump 129% ↗

August 14, 2025

Via The Motley Fool

Topics Intellectual Property

This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday ↗

July 31, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 09, 2025

Via Benzinga

Which stocks are moving on Monday? ↗

April 07, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Keep an eye on the top gainers and losers in Monday's session. ↗

April 07, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 07, 2025

Via Benzinga

Monday's session: gap up and gap down stocks ↗

April 07, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Gene Therapy For Fatal Rare Disease-Associated Heart Condition - Lexeo Therapeutics Candidate Shows Improvements In Trials ↗

April 07, 2025

Lexeo reported strong interim results for LX2006 in ataxia cardiomyopathy, with plans to start a registrational study by early 2026.

Via Benzinga

Pharma Frenzy: Volatility Ignites Biotech Sector

March 25, 2025

Two biotech companies have surged on recent developments, illustrating biotech's volatility and prompting investors to evaluate potential long-term value.

Via MarketBeat

Lexeo Therapeutics Sees Biggest Retail Follower Surge Among Biotech Stocks After Record-Breaking Rally: What's The Big Draw? ↗

March 25, 2025

The company reported an adjusted Q4 loss of $0.78 per share, beating expectations for a $0.81 loss.

Via Stocktwits

What's going on in today's session ↗

March 24, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 24, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Monday's session. ↗

March 24, 2025

Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

February 20, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 13, 2024

Via Benzinga

LXEO Stock Earnings: Lexeo Therapeutics Beats EPS for Q2 2024 ↗

August 12, 2024

LXEO stock results show that Lexeo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.